Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-019314

Director sold 17,471 shares at an average $40.33 ($704,519)

  • Director acquired 17,471 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MERRIMAN RONALD · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-22 Exercise or conversion : show line 1 in the form +7,118 $34.41 $244,895 24,925 D
2017-05-22 Sale : show line 2 in the form −7,118 $40.31 $286,917 17,807 D
2017-05-22 Exercise or conversion : show line 3 in the form +10,353 $30.50 $315,792 28,160 D
2017-05-22 Sale : show line 4 in the form −10,353 $40.34 $417,602 17,807 D
Open-market sales · 17,471 sh · avg $40.33 · $704,519

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-05-22 Exercise or conversion : show line 5 in the form Non-qualified Stock Option (Right to Buy) −7,118 0 D
2017-05-22 Exercise or conversion : show line 6 in the form Non-qualified Stock Option (Right to Buy) −10,353 0 D
Loading xslF345X03/form4.xml…